David M. Burger

Nijmegen, GE, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 409 publications

Pharmacokinetic modeling to support WHO-weight band dosing of a new pediatric darunavir/ritonavir (120/20 mg) fixed-dose combination tablet for children at least 3 years old and weighing 10 to less than 35 kg.

Pharmacokinetic modeling to support WHO-weight band dosing of a new pediatric darunavir/ritonavir (120/20 mg) fixed-dose combination tablet for children at least 3 years old and weighing 10 to less than 35 kg.

Journal: Journal of acquired immune deficiency syndromes (1999)

Published: August 21, 2026

Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.

Population pharmacokinetics of ritonavir-boosted atazanavir in subsequent-line treatment in African children with HIV.

Journal: Antimicrobial agents and chemotherapy

Published: July 17, 2026

Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpoint.

Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpoint.

Journal: EBioMedicine

Published: May 24, 2026

Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.

Expediting a UNIVERSAL first-line regimen of a dolutegravir-emtricitabine-tenofovir alafenamide fixed-dose ratio for children living with HIV older than 4 weeks: a 24-week, open-label, single-arm, phase 1-2, pharmacokinetic, safety, and antiviral activity trial.

Journal: The lancet. HIV

Published: March 23, 2026

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025.

Two cases of possible transmitted HIV drug resistance to all currently available integrase inhibitors, the Netherlands, 2025.

Journal: Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin

Published: February 27, 2026

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment.

Pharmacokinetics of abacavir and lamivudine in infants living with HIV with and without rifampicin co-treatment.

Journal: The Journal of antimicrobial chemotherapy

Published: February 19, 2026

Evaluation of drug-drug interactions associated with metamizole in clinical practice.

Evaluation of drug-drug interactions associated with metamizole in clinical practice.

Journal: Expert review of clinical pharmacology

Published: February 10, 2026

Factors influencing counseling on infant feeding options: a qualitative study with women living with HIV and their healthcare professionals in a high-income setting.

Factors influencing counseling on infant feeding options: a qualitative study with women living with HIV and their healthcare professionals in a high-income setting.

Journal: AIDS care

Published: January 27, 2026

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.

Pharmacokinetics and pharmacodynamics of valganciclovir in infants with severe HIV-associated pneumonia in Africa: a sub-study of the EMPIRICAL randomised controlled trial.

Journal: EClinicalMedicine

Published: January 08, 2026

Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.

Exploring the pharmacokinetic mechanisms that affect bictegravir exposure during pregnancy.

Journal: The Journal of antimicrobial chemotherapy

Published: January 06, 2026

Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.

Simulation-Based Predictions to Support the Development of a Pediatric Fixed-Dose Combination of Dolutegravir/Emtricitabine/Tenofovir Alafenamide Fumarate.

Journal: Clinical pharmacokinetics

Published: January 05, 2026

Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial.

Empirical treatment with valganciclovir in infants living with HIV and hospitalised with severe pneumonia in Africa: a multicentre, open-label, factorial, randomised, controlled, superiority trial.

Journal: Lancet (London, England)

Published: December 11, 2025

Showing 1-12 of 409

Last Updated: 09/26/2026